I was led to believe that when Anteris was allowed to sell devices to patients on the trial that the bleeding of cash would stop or at least slow down. Are we at that place yet?
Ann: Plan to Pursue Re-domiciliation, Nasdaq listing and US IPO, page-50
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.55 |
Change
-0.010(0.18%) |
Mkt cap ! $85.91M | |||
| Open | High | Low | Value | Volume |
| $5.31 | $5.60 | $5.31 | $52.23K | 9.674K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 188 | $5.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.69 | 122 | 1 |
View Market Depth
| Last trade - 15.11pm 08/08/2025 (20 minute delay) ? |
| AVR (ASX) Chart |